International Stem Cell Policy Program

Human stem cell research — encompassing embryonic, adult and induced pluripotent stem cell research — is viewed as a critical area of study by much of the science and medical community. While a significant amount of research is needed before embryonic or induced pluripotent stem cells can be used in therapy, these cells have the potential to cure or treat debilitating injuries and diseases such as spinal cord injury, Parkinson’s disease and diabetes. Understanding stem cells can impact developmental biology, cancer biology, regenerative medicine and other fields of biomedical research.

The mission of the Baker Institute International Stem Cell Policy Program is to bring together scientists, ethicists, policymakers, media experts, and community and business leaders to find new ways to engage the general public in a dialogue on international stem cell policies and the ethical use of stem cells for research. The program includes an international conference series titled “Stem Cells: Saving Lives or Crossing Lines.” The program also sponsors local events and lectures; workshops that bring together scholars and scientists from the international community and conference reports on the workshops; and major public policy research. The program is part of the Baker Institute Science and Technology Policy Program, led by senior fellow Neal Lane  and fellow Kirstin Matthews.